The inflammatory response to miniaturised extracorporeal circulation: a review of the literature

Hunaid A Vohra, Robert Whistance, Amit Modi, Sunil K Ohri, Hunaid A Vohra, Robert Whistance, Amit Modi, Sunil K Ohri

Abstract

Conventional cardiopulmonary bypass can trigger a systemic inflammatory response syndrome similar to sepsis. Aetiological factors include surgical trauma, reperfusion injury, and, most importantly, contact of the blood with the synthetic surfaces of the heart-lung machine. Recently, a new cardiopulmonary bypass system, mini-extracorporeal circulation (MECC), has been developed and has shown promising early results in terms of reducing this inflammatory response. It has no venous reservoir, a reduced priming volume, and less blood-synthetic interface. This review focuses on the inflammatory and clinical outcomes of using MECC and compares these to conventional cardio-pulmonary bypass (CCPB). MECC has been shown to reduce postoperative cytokines levels and other markers of inflammation. In addition, MECC reduces organ damage, postoperative complications and the need for blood transfusion. MECC is a safe and viable perfusion option and in certain circumstances it is superior to CCPB.

Figures

Figure 1
Figure 1
Schematic of the miniaturised extracorporeal circuit (MECC) on the left and of conventional extracorporeal circulation (CECC) on the right.

References

    1. Gibbon JH., Jr. Application of a mechanical heart and lung apparatus to cardiac surgery. Minnesota Medicine. 1954;37(3):171–185.
    1. Penttilä HJ, Lepojärvi MVK, Kiviluoma KT, Kaukoranta PK, Hassinen IE, Peuhkurinen KJ. Myocardial preservation during coronary surgery with and without cardiopulmonary bypass. The Annals of Thoracic Surgery. 2001;71(2):565–570.
    1. Gundry SR, Romano MA, Shattuck OH, Razzouk AJ, Bailey LL. Seven-year follow-up of coronary artery bypasses performed with and without cardiopulmonary bypass. The Journal of Thoracic and Cardiovascular Surgery. 1998;115(6):1273–1278.
    1. Borst C, Gründeman PF. Minimally invasive coronary artery bypass grafting: an experimental perspective. Circulation. 1999;99(11):1400–1403.
    1. Royston D. The inflammatory response and extracorporeal circulation. Journal of Cardiothoracic and Vascular Anesthesia. 1997;11(3):341–354.
    1. Ascione R, Lloyd CT, Underwood MJ, Lotto AA, Pitsis AA, Angelini GD. Inflammatory response after coronary revascularization with or without cardiopulmonary bypass. The Annals of Thoracic Surgery. 2000;69(4):1198–1204.
    1. Asimakopoulos G. Mechanisms of the systemic inflammatory response. Perfusion. 1999;14(4):269–277.
    1. Warltier DC, Laffey JG, Boylan JF, Cheng DC. The systemic inflammatory response to cardiac surgery: implications for the anesthesiologist. Anesthesiology. 2002;97(1):215–252.
    1. Levy JH, Tanaka KA. Inflammatory response to cardiopulmonary bypass. The Annals of Thoracic Surgery. 2003;75:S715–S720.
    1. Khan NE, De Souza A, Mister R, et al. A randomised comparison of off-pump and on-pump multivessel coronary-artery bypass surgery. The New England Journal of Medicine. 2004;350(1):21–28.
    1. Immer FF, Ackermann A, Gygax E, et al. Minimal extracorporeal circulation is a promising techniques for coronary artery bypass grafting. The Annals of Thoracic Surgery. 2007;84(5):1515–1521.
    1. van Boven W-J, Gerritsen WB, Waanders FG, Haas FJ, Aarts LP. Mini extracorporeal circuit for coronary artery bypass grafting: initial clinical and biochemical results: a comparison with conventional and off-pump coronary artery bypass grafts concerning global oxidative stress and alveolar function. Perfusion. 2004;19(4):239–246.
    1. Van Boven W-JP, Gerritsen WBM, Zanen P, et al. Pneumoproteins as a lung-specific biomarker of alveolar permeability in conventional on-pump coronary artery bypass graft surgery vs mini-extracorporeal circuit: a pilot study. Chest. 2005;127(4):1190–1195.
    1. Prasser C, Abbady M, Keyl C, et al. Effect of a miniaturized extracorporeal circulation (MECCTMSystem) on liver function. Perfusion. 2007;22(4):245–250.
    1. Remadi JP, Rakotoarivelo Z, Marticho P, Benamar A. Prospective randomized study comparing coronary artery bypass grafting with new mini-extracorporeal circulation Jostra System or a standard cardiopulmonary bypass. American Heart Journal. 2006;151(1):198.e1–198.e7.
    1. Fromes Y, Gaillard D, Ponzio O, et al. Reduction of the inflammatory response following coronary bypass grafting with total minimal extracorporeal circulation. European Journal of Cardio-Thoracic Surgery. 2002;22(4):527–533.
    1. Ohata T, Mitsuno M, Yamamura M, et al. Minimal cardiopulmonary bypass attenuates neutrophil activation and cytokine release in coronary artery bypass grafting. Journal of Artificial Organs. 2007;10(2):92–95.
    1. Beghi C, Nicolini F, Agostinelli A, et al. Mini-cardiopulmonary bypass systemml: results of a prospective randomized study. The Annals of Thoracic Surgery. 2006;81(4):1396–1400.
    1. Mazzei V, Nasso G, Salamone G, Castorino F, Tommasini A, Anselmi A. Prospective randomized comparison of coronary bypass grafting with minimal extracorporeal circulation system (MECC) versus off-pump coronary surgery. Circulation. 2007;116(16):1761–1767.
    1. Wiesenack C, Liebold A, Philipp A, et al. Four years' experience with a miniaturized extracorporeal circulation system and its influence on clinical outcome. Artificial Organs. 2004;28(12):1082–1088.
    1. Farneti PA, Sbrana S, Spiller D, et al. Reduction of blood coagulation and monocyte-platelet interaction following the use of a minimal extracorporeal circulation system (Synergy®) in coronary artery bypass grafting (CABG) Perfusion. 2008;23(1):49–56.
    1. Skrabal CA, Steinhoff G, Liebold A. Minimizing cardiopulmonary bypass attenuates myocardial damage after cardiac surgery. ASAIO Journal. 2007;53(1):32–35.
    1. Aldea GS, Soltow LO, Chandler WL, et al. Limitation of thrombin generation, platelet activation, and inflammation by elimination of cardiotomy suction in patients undergoing coronary artery bypass grafting treated with heparin-bonded circuits. The Journal of Thoracic and Cardiovascular Surgery. 2002;123(4):742–755.
    1. Westerberg M, Bengtsson A, Jeppsson A. Coronary surgery without cardiotomy suction and autotransfusion reduces the postoperative systemic inflammatory response. The Annals of Thoracic Surgery. 2004;78(1):54–59.
    1. Mazzone A, De Servi S, Mazzucchelli I, et al. Increased concentrations of inflammatory mediators in unstable angina: correlation with serum troponin T. Heart. 2001;85(5):571–575.
    1. De Servi S, Mariani M, Mariani G, Mazzone A. C-reactive protein increase in unstable coronary disease: cause or effect? Journal of the American College of Cardiology. 2005;46(8):1496–1502.
    1. Manginas A, Bei E, Chaidaroglou A, et al. Peripheral levels of matrix metalloproteinase-9, interleukin-6, and C-reactive protein are elevated in patients with acute coronary syndromes: correlations with serum troponin I. Clinical Cardiology. 2005;28(4):182–186.
    1. Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. The New England Journal of Medicine. 2007;357(11):1121–1135.
    1. Buckberg GD. Update on current techniques of myocardial protection. The Annals of Thoracic Surgery. 1995;60(3):805–814.
    1. Davies SW, Duffy JP, Wickens DG, et al. Time-course of free radical activity during coronary artery operations with cardiopulmonary bypass. The Journal of Thoracic and Cardiovascular Surgery. 1993;105(6):979–987.
    1. Benzie IFF, Chung W-Y, Tomlinson B. Simultaneous measurement of allantoin and urate in plasma: analytical evaluation and potential clinical application in oxidant:antioxidant balance studies. Clinical Chemistry. 1999;45(6):901–904.
    1. Raman JS, Kochi K, Morimatsu H, Buxton B, Bellomo R. Severe ischemic early liver injury after cardiac surgery. The Annals of Thoracic Surgery. 2002;74(5):1601–1606.
    1. Paparella D, Yau TM, Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. European Journal of Cardio-Thoracic Surgery. 2002;21(2):232–244.
    1. El Habbal MH, Smith LJ, Elliott MJ, Strobel S. Cardiopulmonary bypass tubes and prime solutions stimulate neutrophil adhesion molecules. Cardiovascular Research. 1997;33(1):209–215.
    1. Kukielka GL, Smith CW, Manning AM, Youker KA, Michael LH, Entman ML. Induction of interleukin-6 synthesis in the myocardiumml: potential role in postreperfusion inflammatory injury. Circulation. 1995;92(7):1866–1875.
    1. Levy JH. Anaphylactic Reactions in Anesthesia and Intensive Care. 2nd edition. Stoneham, Mass, USA: Butterworth-Heinemann; 1992.
    1. Chai PJ. Soluble complement receptor-1 protects heart, lung, and cardiac myofilament function from cardiopulmonary bypass damage. Circulation. 2000;101(5):541–546.
    1. Yamamoto H, Moriyama Y, Hisatomi K, Yotsumoto G, Taira A, Sakata R. A leukocyte depleting filter reduces endothelial cell dysfunction and improves transplanted canine heart function. Journal of Heart and Lung Transplantation. 2001;20(6):670–678.
    1. Kukielka GL, Smith CW, Manning AM, Youker KA, Michael LH, Entman ML. Induction of interleukin-6 synthesis in the myocardiumml: potential role in postreperfusion inflammatory injury. Circulation. 1995;92(7):1866–1875.
    1. Haeffner-Cavaillon N, Roussellier N, Ponzio O, et al. Induction of interleukin-1 production in patients undergoing cardiopulmonary bypass. The Journal of Thoracic and Cardiovascular Surgery. 1989;98(6):1100–1106.
    1. Qing M, Vazquez-Jimenez JF, Klosterhalfen B, et al. Influence of temperature during cardiopulmonary bypass on leukocyte activation, cytokine balance, and post-operative organ damage. Shock. 2001;15(5):372–377.
    1. Belaaouaj AA, Kim KS, Shapiro SD. Degradation of outer membrane protein A in Escherichia coli killing by neutrophil elastase. Science. 2000;289(5482):1185–1187.
    1. Butler J, Parker D, Pillai R, Westaby S, Shale DJ, Rocker GM. Effect of cardiopulmonary bypass on systemic release of neutrophil elastase and tumor necrosis factor. The Journal of Thoracic and Cardiovascular Surgery. 1993;105(1):25–30.
    1. Maisel WH, Rawn JD, Stevenson WG. Atrial fibrillation after cardiac surgery. Annals of Internal Medicine. 2001;135(12):1061–1073.
    1. Arefieva TI, Provatorov SI, Samko AN, et al. Monocyte integrin expression and monocyte-platelet complex formation in humans with coronary restenosis. Clinical and Experimental Pharmacology and Physiology. 2001;28(10):804–808.
    1. Gorbet MB, Sefton MV. Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes. Biomaterials. 2004;25(26):5681–5703.
    1. Smith BR, Rinder HM, Rinder CS. Cardiopulmonary bypass. In: Michelson AD, editor. Platelets. San Diego, Calif, USA: Academic Press; 2002. pp. 727–741.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다